医疗公司的首席执行官将在一个重要的健康会议上讨论其FDA批准的脊髓刺激技术. ONWARD Medical's CEO will discuss its FDA-approved spinal cord stimulation technology at a major health conference.

Onward Medical,一家开发脊髓刺激疗法的公司,其首席执行官Dave Marver将出席1月15日第43届J.P.Morgan健康护理年会。 ONWARD Medical, a company developing spinal cord stimulation therapies, will have its CEO, Dave Marver, present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15. 该公司的ARC治疗已经收到了来自FDA的10个突破性装置指认,其ARC-EX系统现已在美国商业上可供使用。 The company's ARC Therapy has received ten Breakthrough Device Designations from the FDA, and its ARC-EX System is now commercially available in the U.S. 专题介绍将进行现场网播,并存档30天。 The presentation will be live webcast and archived for 30 days.